Ultrafast solvent removal delivers high-loading of amorphous small-molecule drugs in polymeric microspheres with predictable in vivo performance.

The clinical translation of long-acting injectable microspheres has been persistently hindered by manufacturing inconsistencies inherent to conventional batch processing. This variability compromises product quality and obstructs the establishment of…

Preview only. Read the full abstract at the source